Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income including noncontrolling interests	$ 11,028	$ 279,839	$ 256,988
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	107,227	93,881	104,606
Impairment and other charges	40,717	16,699	122,227
Share-based compensation expenses related to equity classified awards	29,986	47,925	52,908
Non-cash restructuring and other related charges	336,744	4,329	5,359
Amortization and write-offs of program rights	1,008,470	909,339	923,886
Amortization of deferred carriage fees	34,234	29,709	28,231
Unrealized foreign currency transaction loss (gain)	8,692	(16,882)	3,099
Amortization of deferred financing costs and discounts on indebtedness	7,733	7,729	8,005
Loss on extinguishment of debt	0	22,074	2,908
Bad debt expense (recoveries)	2,202	5,337	(2,843)
Deferred income taxes	(50,689)	34,010	23,159
Gains on investments	(4,084)	(1,306)	(97,617)
Write-down of non-marketable equity securities and note receivable	0	0	20,000
Other, net	(7,667)	(7,216)	(594)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	70,371	(56)	63,337
Prepaid expenses and other assets	(34,069)	(183,861)	64,060
Program rights and obligations, net	(1,347,351)	(1,297,782)	(850,013)
Income taxes payable	(148)	(3,467)	6,703
Deferred revenue	(63,622)	126,832	7,202
Deferred carriage fees, net	(39,590)	(53,065)	(8,833)
Accounts payable, accrued liabilities and other liabilities	71,650	129,406	15,958
Net cash provided by operating activities	181,834	143,474	748,736
Cash flows from investing activities:
Capital expenditures	(44,272)	(42,572)	(46,595)
Return of capital from investees	1,771	0	1,872
Acquisition of investments	(5,002)	(30,273)	(5,440)
Loans to investees	(2,456)	0	0
Cash paid on distribution of business	0	(7,052)	0
Principal payments received on loans to investees	720	20,000	5,000
Payments for acquisitions of businesses, net of cash acquired	0	(62,055)	0
Proceeds from sale of investments	9,854	95,370	10,000
Net cash used in investing activities	(39,385)	(26,582)	(35,163)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	0	986,000	6,000
Principal payments on long-term debt	(33,750)	(1,016,500)	(262,250)
Deemed repurchases of restricted stock units	(22,332)	(32,886)	(15,967)
Purchase of treasury stock	0	0	(356,701)
Proceeds from stock option exercises	0	9,795	0
Principal payments on finance lease obligations	(3,576)	(3,800)	(3,261)
Purchase of noncontrolling interests	(2,500)	0	0
Contributions from noncontrolling interests	0	2,702	0
Distributions to noncontrolling interests	(34,957)	(29,414)	(15,819)
Net cash used in financing activities	(97,115)	(84,103)	(647,998)
Net increase in cash and cash equivalents from operations	45,334	32,789	65,575
Effect of exchange rate changes on cash and cash equivalents	(7,553)	(29,094)	6,781
Cash and cash equivalents at beginning of year	892,221	888,526	816,170
Cash and cash equivalents at end of year	$ 930,002	$ 892,221	$ 888,526